医学
肺结核
斯科普斯
心理干预
肺结核
荟萃分析
人口学
流行病学
中东
统计的
随机效应模型
环境卫生
人类免疫缺陷病毒(HIV)
梅德林
全球卫生
流行
发展中国家
结核病治疗
中东呼吸综合征冠状病毒
年轻人
系统回顾
女性
病因学
伊朗南部
科学网
作者
Oumar Abakar MAHAMED,Sandokane Noussissy Hounnoukon,Soraya Laraqui Houssaini,Imane El Faziki,Meryeme Kirat,Karima El Rhazi
标识
DOI:10.1136/bmjresp-2025-003887
摘要
Background Multidrug-resistant tuberculosis (MDR-TB) is a constraining challenge for tuberculosis (TB) control worldwide. The Middle East and North African (MENA) region represents a significant part of the global MDR-TB burden. Aim To estimate the pooled prevalence of MDR-TB and its determinants in the MENA region. Methods We searched for studies published in English and French on the subject up to 31 January 2026 on Web of Science, PubMed, Scopus and Cochrane, without time restriction. Original studies reporting data on the prevalence of MDR-TB in individuals living in the MENA region were selected. The meta-analysis was done using the random effects model considering the heterogeneity among the included studies and I 2 statistic was used to assess the heterogeneity. Results A total of 1239 articles were identified and 25 studies from 6 countries were included in this review. The prevalence of MDR-TB in the MENA region ranged from 0% (95% CI 0% to 4.1%) to 17.1% (95% CI 10.6% to 25.4%). The pooled prevalence was 3.54% (95% CI 2.18% to 5.72%) with a high heterogeneity, I 2 =95.6%; 95% CI 94.4% to 96.5%. Previous exposition to TB treatment, HIV infection, smoking and the presence of comorbidities were the most reported associated factors. Conclusion This review underscores the persistence of MDR-TB in the MENA region, suggesting insufficiency in TB control. Multisectoral interventions integrating strong prevention measures, standardised treatment protocols and measures to enhance treatment adherence should be implemented.
科研通智能强力驱动
Strongly Powered by AbleSci AI